New ‘Evolve’ recommendations to improve obstetric and paediatric care

Date published:
08 Aug 2017

As a part of the Evolve initiative, last week the College released a series of new recommendations to help avoid unnecessary and potentially harmful tests and procedures carried out with pregnant women and children. 

These new lists come from the Society of Obstetric Medicine of Australia and New Zealand and the Australasian Paediatric Endocrine Group. They include recommendations not to use the D-Dimer test to determine venous thromboembolism in pregnant women and not to prescribe aromatase inhibitor hormone therapy for height promotion.

These lists are part of the Evolve physician-led initiative. There are now 17 Evolve lists published, with a further 15 in development.

The full list of Evolve recommendations can be downloaded at this website:

Close overlay